3rd Quarter - Amendment
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2015 | $310,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Mar 22, 2016 | $290,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BARDI New | — |
| MOLLY RYAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.